Try our beta test site
1 study found for:    23688323 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Efficacy, Safety, and Tolerability of SAR231893 (REGN668) in Patients With Persistent Moderate to Severe Eosinophilic Asthma
Condition: Asthma
Interventions: Biological: SAR231893 (REGN668);   Drug: placebo;   Drug: Fluticasone/Salmeterol combination;   Drug: Fluticasone;   Drug: Albuterol

Study has passed its completion date and status has not been verified in more than two years.